These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

905 related items for PubMed ID: 25536958

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Successful twin pregnancy achieved by assisted reproductive technology in a patient with polycystic ovary syndrome with complex atypical endometrial hyperplasia treated with levonorgestrel-releasing intrauterine system.
    Ercan CM, Duru NK, Sakinci M, Alanbay I, Karasahin KE, Baser I.
    Gynecol Endocrinol; 2010 Feb; 26(2):125-8. PubMed ID: 20074021
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Management of Endometrial Hyperplasia With a Levonorgestrel-Releasing Intrauterine System: A Korean Gynecologic-Oncology Group Study.
    Kim MK, Seong SJ, Kim JW, Jeon S, Choi HS, Lee IH, Lee JH, Ju W, Song ES, Park H, Ryu HS, Lee C, Kang SB.
    Int J Gynecol Cancer; 2016 May; 26(4):711-5. PubMed ID: 26905333
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of a levonorgestrel-releasing intrauterine system for treating endometrial hyperplasia in patients with polycystic ovary syndrome.
    Lin M, Xu X, Wang Y, Hu Y, Zhao Y.
    Gynecol Obstet Invest; 2014 May; 78(1):41-4. PubMed ID: 24852134
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Exposure to human chorionic gonadotropin during in vitro maturation does not improve the maturation rate and developmental potential of immature oocytes from patients with polycystic ovary syndrome.
    Ge HS, Huang XF, Zhang W, Zhao JZ, Lin JJ, Zhou W.
    Fertil Steril; 2008 Jan; 89(1):98-103. PubMed ID: 17524398
    [Abstract] [Full Text] [Related]

  • 12. Levonorgestrel-releasing intrauterine system effects on metabolic variables in PCOS.
    Ji L, Jin L, Shao MJ, Hu M, Xu J.
    Gynecol Endocrinol; 2023 May 05; 39(1):2208667. PubMed ID: 37182541
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study.
    Gallos ID, Krishan P, Shehmar M, Ganesan R, Gupta JK.
    Hum Reprod; 2013 Nov 05; 28(11):2966-71. PubMed ID: 23975691
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Successful pregnancy following insertion of a levonorgestrel-releasing intrauterine system in two infertile patients with complex atypical endometrial hyperplasia.
    Qi X, Zhao W, Duan Y, Li Y.
    Gynecol Obstet Invest; 2008 Nov 05; 65(4):266-8. PubMed ID: 18196936
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Efficacy of the levonorgestrel intrauterine system (LNG-IUS) in the prevention of the atypical endometrial hyperplasia and endometrial cancer: retrospective data from selected obese menopausal symptomatic women.
    Morelli M, Di Cello A, Venturella R, Mocciaro R, D'Alessandro P, Zullo F.
    Gynecol Endocrinol; 2013 Feb 05; 29(2):156-9. PubMed ID: 23134558
    [Abstract] [Full Text] [Related]

  • 20. Comparative effects of different treatments based on the levonorgestrel intrauterine system in endometrial carcinoma and endometrial hyperplasia patients: a network meta-analysis.
    Tao M, Wu T, Zhou X, Du X, Ling K, Liang Z.
    Arch Gynecol Obstet; 2024 Sep 05; 310(3):1315-1329. PubMed ID: 38980346
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 46.